Sep 14, 11 02:43PM
|
0 comments
Last year, after Dr. Caroline Hastings and I received the U.S. Food and Drug Administration orphan drug designation for Hydroxy-propyl-beta-cyclodextrin (HPBCD) for the treatment of Niemann Pick Type C disease, I was contacted by Sue French. Sue lives in the United Kingdom and her son William is also afflicted with the rare and fatal genetic [...]
Contributor
More from this contributor
- Rare Disease Day Logo and Ribbon...
- Is Your Disease on the RARE List...
- Rare Disease Day 2012 – Sp...
- Meet The Children Who Are Resist...
Comments
To add a comment to the original post, click here.
You must be signed in to post a comment.
Sign in nowThere are no comments for this post.